ZDSD
DEAD

Serial Number

87511923

Owner

Crown Bioscience Inc.

Attorney

Yi Zhang

First Use Date

Jan 1, 2016

Filing Date

Jun 30, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ZDSD Trademark

Serial Number: 87511923 • Registration: 5489977

ZDSD is a trademark filed by Crown Bioscience Inc. on June 30, 2017. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Crown Bioscience Inc. (29 trademarks)

Santa Clara, CA 95054

Entity Type: 03

Trademark Details

Filing Date

June 30, 2017

Registration Date

June 12, 2018

First Use Anywhere

January 1, 2016

First Use in Commerce

January 1, 2016

Published for Opposition

March 27, 2018

Cancellation Date

December 27, 2024

Goods & Services

Drug use screening services; Drug use testing services; Drug, alcohol and DNA screening for medical purposes; Alternative medicine services; Health care services, namely, health and wellness programs in field of childhood obesity; Medical services, namely, pre-employment drug screening; Providing information in the field of diabetes

Drug discovery services; Pharmaceutical research and development; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific research and development; Scientific study and research in the field(s) of medicines for treating obesity, metabolic syndrome, and diabetes; Biochemical research and development; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Research and development and consultation related thereto in the field of drugs for treating obesity, metabolic syndrome, and diabetes; Research and development and consultation related thereto in the field of mouse model for obesity, metabolic syndrome, and diabetes drug development; Research and development in the field of mouse model for obesity, metabolic syndrome, and diabetes drug development; Research and development in the field of drugs for treating obesity, metabolic syndrome, and diabetes; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 27, 2024 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 12, 2023 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 28, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 28, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 28, 2021 REAP
REGISTERED-PRINCIPAL REGISTER
Jun 12, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 27, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 27, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 7, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 17, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 16, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 16, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 17, 2017 GNRN
NON-FINAL ACTION E-MAILED
Aug 17, 2017 GNRT
NON-FINAL ACTION WRITTEN
Aug 17, 2017 CNRT
ASSIGNED TO EXAMINER
Aug 16, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2017 NWOS
NEW APPLICATION ENTERED
Jul 4, 2017 NWAP